Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
about
Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
description
clinical trial
@en
klinisch onderzoek
@nl
name
Bortezomib Plus Tacrolimus and ...... lood Stem Cell Transplantation
@en
type
label
Bortezomib Plus Tacrolimus and ...... lood Stem Cell Transplantation
@en
prefLabel
Bortezomib Plus Tacrolimus and ...... lood Stem Cell Transplantation
@en
P4844
P1476
Phase I/II Trial of Bortezomib ...... lood Stem Cell Transplantation
@en
P3098
NCT00369226
P580
2006-08-01T00:00:00Z
P582
2010-07-01T00:00:00Z